Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction
Cleveland Clinic and IBM announced the development of a quantum machine learning model designed to predict cancer neoantigens, potentially improving the selection of immunogenic peptide sequences for personalized cancer vaccines.
OutlookPlausible
The model is refined on larger datasets and integrated into a hybrid classical–quantum pipeline for neoantigen screening in early‑phase clinical trials.